Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Home-based transcranial direct current stimulation (tDCS) for depression in borderline personality disorder

Official title: Efficacy Study of Enhanced Home-Based Transcranial Direct Current Stimulation (tDCS) on Depressive Symptoms in Borderline Personality Disorder (BPD): A Pilot Randomized Controlled Trial

Run by Ciusss de L'Est de l'Île de Montréal · NCT06972368 · Data updated 2026-11-12

This project will see if 14 home-based tDCS sessions, compared with sham, can reduce depressive symptoms in adults with borderline personality disorder and moderate-to-severe depression.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorCiusss de L'Est de l'Île de Montréal
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJanuary 1, 2027
Study endsJune 1, 2027
Registry record updatedMay 6, 2026
Trial IDNCT06972368 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with DSM-IV borderline personality disorder experiencing a moderate-to-severe depressive episode (MADRS ≥ 20), who have stable psychiatric care, access to a smartphone and internet, and can independently use and pick up/return a tDCS device are ideal candidates.

Probably not a fit

People with contraindications to tDCS (for example epilepsy, certain scalp conditions, history of bipolar disorder), pregnancy, or who cannot safely or independently use the device are unlikely to benefit from this home-based intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a double-blind, randomized trial in which 60 adults with DSM-IV borderline personality disorder and a moderate-to-severe depressive episode will be randomized to 14 sessions of active or sham home-based tDCS following a two-week online psychoeducation. Sessions are delivered at home with participants required to pick up and return the device at the study center, and feasibility in both remote and urban settings is the primary outcome. Secondary outcomes include preliminary efficacy on depressive symptoms, while exploratory outcomes examine neuropsychological and psychosocial functioning, anxiety, sleep, physical activity, addiction, and the feasibility of using a smartwatch as an outcome measure. The trial will also explore which sociodemographic and clinical factors predict the best response to tDCS and will compare active stimulation to sham in a blinded design.

Why it matters

Potential benefit: If successful, this approach could provide an accessible at-home treatment option to help reduce depressive symptoms and improve functioning for people with BPD.

How similar studies have gone: Noninvasive stimulation of the DLPFC with tDCS has shown promise for depression and some preliminary benefit for BPD symptoms, but home-based tDCS specifically in BPD populations is largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. To be aged between 18 and 65.
2. To meet the DSM-IV criteria for BPD.
3. To present a moderate depressive episode, defined as a MADRS score ≥ 20 (V1 and V3).
4. To be capable to consent to participate in the study.
5. To speak either French or English.
6. Participants must have a prescribing doctor or mental health professional responsible
7. To maintain a stable psychopharmacological and psychotherapeutic intervention.
8. To have access to internet an a smartphone.
9. To demonstrate proficiency in independently using a tDCS device.
10. To be able to pick up and return the remote tDCS device.

Exclusion Criteria:

\- 1. To have a history of Epilepsy. 2. To have a contraindication for tDCS Medical Devices. 3. To have a history of Cerebrovascular Surgery. 4. To present scalp Conditions Affecting tDCS Electrode Placement. 5. To have a history of bipolar disorder. 6. To present social or medical conditions limiting the autonomous use of remote tDCS.

7\. To be pregnant. 8. To be currently undergoing neuromodulation treatment. 9. To be currently using benzodiazepines.

Where it's running

  • Iusmm
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.